Entrada Therapeutics, Inc. · NASDAQ:TRDA

Parmar Kush sold 155,255 Entrada Therapeutics, Inc. shares (Form 4)

Traded Aug 6 to Aug 10, 2026 · Filed Aug 10, 2026

From Aug 6 to Aug 10, 2026, Parmar Kush (Director) sold 155,255 Entrada Therapeutics, Inc. shares at an average US$6.95 for US$1.08M, leaving 2,691,337 shares. Filed Aug 10, 2026 (Form 4).

Sold
155,255 shares
Price
US$6.95 average (US$6.85 to US$7.00)
Value
US$1.08M
Holding after
2,691,337 shares (held indirectly)
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 6, 2026Common StockSale10,494US$7.002,836,098Indirect
Aug 7, 2026Common StockSale52,317US$6.852,783,781Indirect
Aug 10, 2026Common StockSale92,444US$7.002,691,337Indirect

Source

View original at SEC

Related